Preloading with L-BPA, L-tyrosine and L-DOPA enhances the uptake of [18F]FBPA in human and mouse tumour cell lines.

[1]  C. Kuntner,et al.  Automated electrophilic radiosynthesis of [¹⁸F]FBPA using a modified nucleophilic GE TRACERlab FXFDG. , 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  I. Kato,et al.  Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2 , 2015, Cancer science.

[3]  T. Watabe,et al.  FBPA PET in boron neutron capture therapy for cancer: prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model , 2014, EJNMMI Research.

[4]  G. Kabalka,et al.  Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models. , 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[5]  J. Itami,et al.  Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells. , 2013, Nuclear medicine and biology.

[6]  G. Jori,et al.  Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature. , 2013, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[7]  A. Paetau,et al.  L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study. , 2011, International journal of radiation oncology, biology, physics.

[8]  T. Gorlia,et al.  Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential. , 2010, The British journal of radiology.

[9]  G. Mazzini,et al.  Extra-corporeal liver BNCT for the treatment of diffuse metastases: what was learned and what is still to be learned. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[10]  K. Ishii,et al.  PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[11]  H. Minn,et al.  Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[12]  C. Cametti,et al.  Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[13]  M. Yliperttula,et al.  Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  C. Cametti,et al.  L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy. , 2008, International journal of radiation oncology, biology, physics.

[15]  L. Collette,et al.  Uptake of two 10B‐compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001) , 2007, International journal of cancer.

[16]  L. Salford,et al.  Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  G. Mazzini,et al.  Clinical lessons from the first applications of BNCT on unresectable liver metastases. , 2006 .

[18]  M. Vicente,et al.  Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects , 2005, Clinical Cancer Research.

[19]  M. Palacín,et al.  Identification of LAT4, a Novel Amino Acid Transporter with System L Activity* , 2005, Journal of Biological Chemistry.

[20]  Emilija Veljkovic,et al.  SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  Jeng-Jong Hwang,et al.  Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  E. Babu,et al.  Identification of a Novel System L Amino Acid Transporter Structurally Distinct from Heterodimeric Amino Acid Transporters* , 2003, Journal of Biological Chemistry.

[23]  T. L. Nichols,et al.  Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. , 2002, Medical physics.

[24]  Y. Kanai,et al.  Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. , 2001, Biochimica et biophysica acta.

[25]  A. Wittig,et al.  Mechanisms of Transport of p-Borono-Phenylalanine through the Cell Membrane In Vitro , 2000, Radiation research.

[26]  K. Ono,et al.  Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  L. Feinendegen,et al.  Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells. , 1994, Cancer research.

[28]  Hiroshi Fukuda,et al.  TREATMENT OF MALIGNANT MELANOMA BY SINGLE THERMAL NEUTRON CAPTURE THERAPY WITH MELANOMA-SEEKING 10B-COMPOUND , 1989, The Lancet.

[29]  J. Coderre,et al.  Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy. , 1987, Cancer research.

[30]  M. Kilberg,et al.  The regulation of neutral amino acid transport in mammalian cells. , 1983, Biochimica et biophysica acta.

[31]  K. Ishiwata,et al.  4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.